Literature DB >> 32592804

A 3'-tRNA-derived fragment enhances cell proliferation, migration and invasion in gastric cancer by targeting FBXO47.

Fei Zhang1, Jinxin Shi1, Zhonghua Wu1, Peng Gao1, Weixu Zhang1, Bicheng Qu1, Xin Wang1, Yongxi Song2, Zhenning Wang3.   

Abstract

Increasing evidence demonstrates that tRNA-derived fragments (tRFs) exert important effects and are dysregulated in various human cancer types. However, their roles in gastric cancer (GC) remain unknown. Here we identified the functional effects of tRF-3019a (derived from tRNA-Ala-AGC-1-1) in GC. We demonstrated that tRF-3019a was upregulated in GC tissues and cell lines. Phenotypic studies revealed that tRF-3019a overexpression enhances GC cell proliferation, migration and invasion. Conversely, tRF-3019a knockdown inhibits GC cell malignant activities. Mechanistic investigation implies that tRF-3019a directly regulates tumor suppressor gene FBXO47. Furthermore, tRF-3019a levels may discriminate GC tissues from nontumorous tissues. Taken together, our results reveal that tRF-3019a modulates GC cell proliferation, migration and invasion by targeting FBXO47, and it may serve as a potential diagnostic biomarker for GC.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; FBXO47; Gastric cancer; tRNA-derived fragment

Mesh:

Substances:

Year:  2020        PMID: 32592804     DOI: 10.1016/j.abb.2020.108467

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

Review 1.  tRNA-derived fragments (tRFs) in cancer.

Authors:  Yuri Pekarsky; Veronica Balatti; Carlo M Croce
Journal:  J Cell Commun Signal       Date:  2022-08-29       Impact factor: 5.908

2.  A Systematic Review of tRNA-Derived Small non-Coding RNAs as Diagnostic and Prognostic Markers in Cancer.

Authors:  Liyun Gao; Lin Xu; Xin Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5'-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment Outcome.

Authors:  Maria-Alexandra Papadimitriou; Margaritis Avgeris; Panagiotis Levis; Evangelia Ch Papasotiriou; Georgios Kotronopoulos; Konstantinos Stravodimos; Andreas Scorilas
Journal:  Cancers (Basel)       Date:  2020-12-06       Impact factor: 6.639

4.  Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jun Li; Lei Jin; Yuan Gao; Peng Gao; Le Ma; Bei Zhu; Xu Yin; Shizhen Sui; Shuai Chen; Zijian Jiang; Chunfu Zhu
Journal:  J Clin Lab Anal       Date:  2021-03-06       Impact factor: 2.352

5.  Identifying Differentially Expressed tRNA-Derived Small Fragments as a Biomarker for the Progression and Metastasis of Colorectal Cancer.

Authors:  Hui Chen; Zhiying Xu; Hua Cai; Ya Peng; Li Yang; Zhen Wang
Journal:  Dis Markers       Date:  2022-01-06       Impact factor: 3.434

6.  Expression Profiles of tRNA-Derived Small RNAs and Their Potential Roles in Primary Nasopharyngeal Carcinoma.

Authors:  Zhaoyi Lu; Kai Su; Xiaomin Wang; Mingjie Zhang; Shiyin Ma; Hui Li; Yuanzheng Qiu
Journal:  Front Mol Biosci       Date:  2021-12-20

7.  Elucidating the Role of Serum tRF-31-U5YKFN8DYDZDD as a Novel Diagnostic Biomarker in Gastric Cancer (GC).

Authors:  Yuejiao Huang; Haiyan Zhang; Xinliang Gu; Shiyi Qin; Ming Zheng; Xiangrong Shi; Chunlei Peng; Shaoqing Ju
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

8.  Serum hsa_tsr016141 as a Kind of tRNA-Derived Fragments Is a Novel Biomarker in Gastric Cancer.

Authors:  Xinliang Gu; Shuo Ma; Bo Liang; Shaoqing Ju
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 9.  tRNA-derived fragments as New Hallmarks of Aging and Age-related Diseases.

Authors:  Ya Yuan; Jiamei Li; Zhi He; Xiaolan Fan; Xueping Mao; Mingyao Yang; Deying Yang
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

10.  tRNA-derived fragments: tRF-Gly-CCC-046, tRF-Tyr-GTA-010 and tRF-Pro-TGG-001 as novel diagnostic biomarkers for breast cancer.

Authors:  Yue Zhang; Zhao Bi; Xiaohan Dong; Miao Yu; Kangyu Wang; Xingguo Song; Li Xie; Xianrang Song
Journal:  Thorac Cancer       Date:  2021-07-13       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.